Home/Filings/4/0001062993-23-002936
4//SEC Filing

MELLETT PAUL J 4

Accession 0001062993-23-002936

CIK 0001177648other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 7:58 PM ET

Size

6.8 KB

Accession

0001062993-23-002936

Insider Transaction Report

Form 4
Period: 2023-02-09
MELLETT PAUL J
Treasurer and CFO
Transactions
  • Sale

    Common Stock

    2023-02-09$53.64/sh4,200$225,28884,263 total
  • Sale

    Common Stock

    2023-02-09$54.41/sh800$43,52883,463 total
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2022.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $53.09 to $54.05, inclusive.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.09 to $54.85, inclusive.

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeother

Related Parties

1
  • filerCIK 0001185034

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 7:58 PM ET
Size
6.8 KB